[email protected]
Maria Van Kerkhove
American Infectious Disease Epidemiologist; Honorary Lecturer at Imperial College
Maria Van Kerkhove is an American infectious disease epidemiologist. With a background in high-threat pathogens, Van Kerkhove specializes in emerging and re-emerging infectious diseases and is based in the Health Emergencies Program at the World Health Organization (WHO). She is the technical lead of COVID-19 response and the head of emerging diseases and zoonosis unit at WHO.
While at Imperial College, Van Kerkhove served as a senior research fellow in the MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology at Imperial College London and a Technical Consultant for the Global Capacities, Alert and Response Cluster of the World Health Organization (WHO). Dr. Van Kerkhove remains a technical consultant for WHO.
Dr. Van Kerkhove served as the liaison between the World Health Organization (WHO) and the MRC Centre for Outbreak Analysis and Modelling. In this role, she developed projects to support WHO activities and policy decision making for influenza, Middle East respiratory syndrome coronavirus (MERS-CoV), yellow fever, Ebola and other emerging diseases. She and Centre staff continue to provide technical assistance to WHO (including to the Global Influenza Programme, the Pandemic and Epidemic Diseases Department, Initiative for Vaccine Research department and the Global Outbreak Alert and Response Network) through the interpretation of available global data, in collaboration with WHO’s member states, regional and country offices and internationally renowned scientists. The centre provides technical support in the areas of influenza, MERS-CoV, polio, malaria, yellow fever, cholera, hepatitis, HIV and meningitis.
Dr. Van Kerkhove is also a member of the WHO Task Force for MERS-CoV. Her work involves providing WHO with epidemiologic and statistical support for the analysis and interpretation of MERS-CoV data for risk assessments, web-based summaries and communications; the development of epidemiologic and serologic investigation protocols for MERS-CoV; and other publications on topics related MERS-CoV.
Related Speakers View all
Martha Stewart
Founder of Martha Stewart Living Omnimedia, Emmy Awa...
|
|
Billie Jean King
Former World #1 Professional Tennis Player & Sports ...
|
|
Michelle Albert
Immediate-Past President of the AHA; Acclaimed Physi...
|
|
Dr. Sharon Malone
Chief Medical Officer at Alloy Women’s Health
|
|
Sonia Hunt
Chief Marketing Officer, TEDx Speaker, #1 Best-Selli...
|
|
Jennifer Weiss-Wolf
Women & Democracy Fellow at the Brennan Center for J...
|
|
Dr. Erkeda DeRouen
Triple Board-Certified Physician, Healthcare Innovat...
|
|
Kathryn Kolbert
Reproductive Rights Attorney; Founder of Athena Cent...
|
|
Joia Mukherjee
Chief Medical Officer, Partners in Health
|
|
Jennifer Nuzzo
Director of the Pandemic Center & Professor of Epide...
|
|
Antonia Villarruel
Dean of Nursing at the University of Pennsylvania; B...
|
|
Claire Sterk
President Emerita & Charles Howard Candler Professor...
|
|
Jasmine Crowe-Houston
Award-Winning Social Entrepreneur, Environmental Adv...
|
|
Jill Hagenkord, MD
Chief Medical Officer of Color Genomics
|
|
Karen DeSalvo
Chief Health Officer at Google, Former Assistant Sec...
|
|
Julia Gillard
Former Prime Minister of Australia, First Woman to H...
|
|
Amy Abernethy
President, Product Development and Chief Medical Off...
|
|
Marilyn Tam
Leadership Speaker, Bestselling Author, Consultant &...
|
|
Brené Brown
Professor at the University of Houston; #1 New York ...
|
|
Sara Blakely
Founder & CEO of SPANX, Innovative Entrepreneur, Wom...
|